I agree that this site is using cookies. You can find further informations here.
X
Bolotin, Shelly
57  results:
OpenAccess-fulltext X
?
1

Comparison of measles IgG enzyme immunoassays (EIA) versus ..:

Lutz, Chelsea S ; Hasan, Alvira Z ; Bolotin, Shelly...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231861/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Determining the Longitudinal Serologic Response to COVID-19..:

Yau, Kevin ; Enilama, Omosomi ; Levin, Adeera...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028441/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

Hepatitis B Blood Donor Screening Data: An Under-Recognized..:

O'Brien, Sheila F ; Reedman, Cassandra N ; Osiowy, Carla...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966614/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
4

Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprev..:

O'Brien, Sheila F ; Caffrey, Niamh ; Yi, Qi-Long...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927354/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

Canadian SARS-CoV-2 serological survey using antenatal seru..:

Atkinson, Andrea ; Albert, Arianne ; McClymont, Elisabeth...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079308/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
6

Population immunity to measles in Canada using Canadian Hea..:

Osman, Selma ; Crowcroft, Natasha ; McLachlan, Elizabeth...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246716/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
7

Seropositivity and risk factors for SARS-CoV-2 infection in..:

Anand, Sonia S ; Arnold, Corey ; Bangdiwala, Shrikant I...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262348/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
8

Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-Bio..:

Yau, Kevin ; Chan, Christopher T ; Abe, Kento T...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053976/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

Différences d'immunogénicité des vaccins anti-SRAS-CoV-2 mR..:

Yau, Kevin ; Chan, Christopher T ; Abe, Kento T...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259426/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

Exploring the reasons for low pertussis vaccine effectivene..:

Hughes, Stephanie L ; Kwong, Jeffrey C ; Schwartz, Kevin L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825901/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

Evaluation of the SARS-CoV-2 Antibody Response to the BNT16..:

Yau, Kevin ; Abe, Kento T ; Naimark, David...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414193/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

COVID-19 Seroprevalence in Ontario; March 27 - October 30, ..:

Bolotin, Shelly ; Tran, Vanessa
doi:10.5281/zenodo.5703272.  , 2021
Link: https://zenodo.org/recor..
 
?
13

SARS-CoV-2 seroprevalence survey estimates are affected by ..:

Bolotin, Shelly ; Tran, Vanessa ; Osman, Selma...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928877/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
14

Assessment of population infection with SARS-CoV-2 in Ontar..:

Bolotin, Shelly ; Tran, Vanessa ; Deeks, Shelley L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728493/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
15

Achieving and sustaining herd immunity to SARS-CoV-2:

Bolotin, Shelly ; Wilson, Sarah ; Murti, Michelle
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315197/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
1-15